New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 18, 2012
08:08 EDTTRIBTrinity Biotech reports Q3 ADR 19.8c, consensus 20c
Reports Q3 revenue $20.9M, consensus $.21.96M
News For TRIB From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 29, 2015
07:42 EDTTRIBTrinity Biotech recent weakness an 'excellent' opportunity, says Stephens
Stephens attributes Trinity Biotech's Q2 miss to HIV and Lyme Disease testing, but said their "lumpiness" is not unexpected and that the company still has organic growth acceleration, margin expansion and the Troponin/BNP submission ahead of it. Stephens sees the recent weakness in the stock as an "excellent" opportunity and maintains its Overweight rating and $22 price target on Trinity shares.
July 28, 2015
09:33 EDTTRIBTrinity Biotech Meritas Troponin ACS study now open
Subscribe for More Information
09:32 EDTTRIBTrinity Biotech reports Q2 EPS 10c, consensus 14c
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use